Back to Directory
Last Updated: 03/06/2026

EnsiliTech

Bristol
Founded 2021
Silica encapsulation platform eliminating cold chain for biologics

EnsiliTech is a biotechnology company developing ensilication, a patented platform technology that encases vaccines, antibodies, and other biologics within a silica matrix to render them thermally stable without refrigeration.

The technology is applicable to existing and new biopharmaceutical formulations, enabling storage and transport at temperatures up to 50°C.

EnsiliTech is developing applications across vaccines and monoclonal antibody therapeutics, with partners including the Centre for Process Innovation.

Company Notes

Previously Known As
Ensilicated Technologies